Rice Hall James & Associates’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Buy |
2,760,314
+750,210
| +37% | +$4.3M | 0.85% | 35 |
|
|
2025
Q1 | $16.4M | Buy |
2,010,104
+639,024
| +47% | +$5.21M | 0.96% | 30 |
|
|
2024
Q4 | $12.9M | Buy |
1,371,080
+398,942
| +41% | +$3.76M | 0.71% | 39 |
|
|
2024
Q3 | $10.4M | Sell |
972,138
-146
| -0% | -$1.56K | 0.56% | 51 |
|
|
2024
Q2 | $9.65M | Sell |
972,284
-56,285
| -5% | -$558K | 0.58% | 51 |
|
|
2024
Q1 | $12.1M | Sell |
1,028,569
-37,396
| -4% | -$441K | 0.69% | 42 |
|
|
2023
Q4 | $15.1M | Sell |
1,065,965
-12,900
| -1% | -$183K | 0.88% | 36 |
|
|
2023
Q3 | $13.1M | Buy |
1,078,865
+30,202
| +3% | +$367K | 0.83% | 38 |
|
|
2023
Q2 | $13.2M | Buy |
1,048,663
+201,804
| +24% | +$2.53M | 0.75% | 41 |
|
|
2023
Q1 | $9.39M | Buy |
846,859
+138,971
| +20% | +$1.54M | 0.53% | 50 |
|
|
2022
Q4 | $8.64M | Sell |
707,888
-6,521
| -0.9% | -$79.6K | 0.5% | 54 |
|
|
2022
Q3 | $7.46M | Sell |
714,409
-199,866
| -22% | -$2.09M | 0.43% | 61 |
|
|
2022
Q2 | $9.82M | Buy |
914,275
+284,658
| +45% | +$3.06M | 0.47% | 57 |
|
|
2022
Q1 | $5.96M | Buy |
629,617
+14,420
| +2% | +$137K | 0.24% | 85 |
|
|
2021
Q4 | $7.11M | Sell |
615,197
-31,701
| -5% | -$366K | 0.25% | 81 |
|
|
2021
Q3 | $6.18M | Sell |
646,898
-3,722
| -0.6% | -$35.5K | 0.23% | 84 |
|
|
2021
Q2 | $6.27M | Sell |
650,620
-140,747
| -18% | -$1.36M | 0.22% | 81 |
|
|
2021
Q1 | $7.82M | Buy |
791,367
+198,835
| +34% | +$1.96M | 0.25% | 79 |
|
|
2020
Q4 | $13.7M | Buy |
+592,532
| New | +$13.7M | 0.48% | 56 |
|